These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16275819)

  • 1. A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndrome.
    Wokke JH; van den Berg LH
    Neurology; 2005 Nov; 65(9):1350-1. PubMed ID: 16275819
    [No Abstract]   [Full Text] [Related]  

  • 2. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Hye JB; Nachamkin I
    Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
    [No Abstract]   [Full Text] [Related]  

  • 3. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Koga M; Yuki N
    Neurology; 2007 Oct; 69(17):1727-8; author reply 1728. PubMed ID: 17954791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
    Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
    J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate mimicry: a new paradigm of autoimmune diseases.
    Yuki N
    Curr Opin Immunol; 2005 Dec; 17(6):577-82. PubMed ID: 16229995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
    Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
    J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
    Yuki N
    J Neurochem; 2007 Nov; 103 Suppl 1():150-8. PubMed ID: 17986150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
    Godschalk PC; van Belkum A; van den Braak N; van Netten D; Ang CW; Jacobs BC; Gilbert M; Endtz HP
    J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Campylobacter jejuni gene associated with immune-mediated neuropathy.
    van Belkum A; van den Braak N; Godschalk P; Ang W; Jacobs B; Gilbert M; Wakarchuk W; Verbrugh H; Endtz H
    Nat Med; 2001 Jul; 7(7):752-3. PubMed ID: 11433317
    [No Abstract]   [Full Text] [Related]  

  • 12. Guillain-Barré syndrome.
    Kountouras J; Deretzi G; Grigoriadis N; Zavos C; Boziki M; Gavalas E; Katsinelos P; Tzilves D; Giouleme O; Lazaraki G
    Lancet Neurol; 2008 Dec; 7(12):1080-1; author reply 1083-5. PubMed ID: 19007730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guillain-Barre syndrome and Campylobacter].
    Engberg JH
    Ugeskr Laeger; 2002 Dec; 164(50):5905-8. PubMed ID: 12553106
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
    Tsang RS
    Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.
    Nyati KK; Prasad KN; Verma A; Singh AK; Rizwan A; Sinha S; Paliwal VK; Pradhan S
    J Neuroimmunol; 2010 Jan; 218(1-2):116-9. PubMed ID: 19913922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

  • 19. Ganglioside mimicry and peripheral nerve disease.
    Yuki N
    Muscle Nerve; 2007 Jun; 35(6):691-711. PubMed ID: 17373701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.
    Yu RK; Usuki S; Ariga T
    Infect Immun; 2006 Dec; 74(12):6517-27. PubMed ID: 16966405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.